Oscar Health, Inc. (NYSE:OSCR) Shares Sold by Zurcher Kantonalbank Zurich Cantonalbank

Zurcher Kantonalbank Zurich Cantonalbank lessened its holdings in shares of Oscar Health, Inc. (NYSE:OSCRFree Report) by 7.9% during the 4th quarter, HoldingsChannel reports. The firm owned 22,626 shares of the company’s stock after selling 1,943 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank’s holdings in Oscar Health were worth $207,000 at the end of the most recent reporting period.

Other large investors have also modified their holdings of the company. Vanguard Group Inc. increased its holdings in shares of Oscar Health by 18.6% in the third quarter. Vanguard Group Inc. now owns 14,127,934 shares of the company’s stock valued at $78,693,000 after purchasing an additional 2,211,743 shares during the last quarter. Ancient Art L.P. raised its holdings in shares of Oscar Health by 91.9% during the 3rd quarter. Ancient Art L.P. now owns 2,793,141 shares of the company’s stock worth $15,558,000 after acquiring an additional 1,337,987 shares during the period. UBS Group AG boosted its position in shares of Oscar Health by 84.7% during the 3rd quarter. UBS Group AG now owns 1,489,498 shares of the company’s stock valued at $8,297,000 after acquiring an additional 683,052 shares during the last quarter. Charles Schwab Investment Management Inc. grew its holdings in shares of Oscar Health by 19.3% in the third quarter. Charles Schwab Investment Management Inc. now owns 1,125,355 shares of the company’s stock valued at $6,268,000 after purchasing an additional 182,206 shares during the period. Finally, Assenagon Asset Management S.A. increased its position in Oscar Health by 48.8% during the third quarter. Assenagon Asset Management S.A. now owns 1,059,529 shares of the company’s stock worth $5,902,000 after purchasing an additional 347,424 shares during the last quarter. Hedge funds and other institutional investors own 75.70% of the company’s stock.

Oscar Health Stock Up 4.2 %

Oscar Health stock opened at $19.78 on Wednesday. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.19 and a current ratio of 1.19. The firm has a 50 day moving average price of $15.35 and a 200 day moving average price of $11.86. Oscar Health, Inc. has a fifty-two week low of $4.72 and a fifty-two week high of $20.60. The company has a market capitalization of $4.54 billion, a PE ratio of -16.48 and a beta of 1.66.

Oscar Health (NYSE:OSCRGet Free Report) last issued its quarterly earnings data on Wednesday, February 7th. The company reported ($0.66) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.74) by $0.08. Oscar Health had a negative return on equity of 29.99% and a negative net margin of 4.62%. The business had revenue of $1.43 billion during the quarter, compared to analysts’ expectations of $1.43 billion. During the same period in the previous year, the firm posted ($1.05) earnings per share. The company’s revenue was up 43.9% on a year-over-year basis. Research analysts expect that Oscar Health, Inc. will post -0.23 earnings per share for the current year.

Analyst Ratings Changes

OSCR has been the topic of several recent analyst reports. TheStreet upgraded shares of Oscar Health from a “d” rating to a “c-” rating in a report on Wednesday, February 21st. Wells Fargo & Company upped their price objective on Oscar Health from $12.00 to $20.00 and gave the company an “overweight” rating in a report on Thursday, February 15th. The Goldman Sachs Group raised their target price on Oscar Health from $8.00 to $16.00 and gave the stock a “neutral” rating in a research note on Friday, February 9th. Finally, Raymond James initiated coverage on Oscar Health in a research note on Friday, March 22nd. They issued an “outperform” rating and a $20.00 price target on the stock. Two analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $13.50.

Read Our Latest Stock Report on Oscar Health

About Oscar Health

(Free Report)

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.

Further Reading

Want to see what other hedge funds are holding OSCR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Oscar Health, Inc. (NYSE:OSCRFree Report).

Institutional Ownership by Quarter for Oscar Health (NYSE:OSCR)

Receive News & Ratings for Oscar Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oscar Health and related companies with MarketBeat.com's FREE daily email newsletter.